Viewing Study NCT04926532


Ignite Creation Date: 2025-12-24 @ 9:42 PM
Ignite Modification Date: 2025-12-30 @ 7:36 AM
Study NCT ID: NCT04926532
Status: UNKNOWN
Last Update Posted: 2021-06-15
First Post: 2019-10-09
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Toripalimab Plus Sorafenib in Patients With Advanced-Stage Hepatocellular Carcinoma
Sponsor: Shanghai Zhongshan Hospital
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2019-08-01
Start Date Type: ACTUAL
Primary Completion Date: 2021-10-31
Primary Completion Date Type: ESTIMATED
Completion Date: 2021-12-31
Completion Date Type: ESTIMATED
First Submit Date: 2019-10-09
First Submit QC Date: None
Study First Post Date: 2021-06-15
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2021-06-14
Last Update Post Date: 2021-06-15
Last Update Post Date Type: ACTUAL